Identification of a novel 11β-HSD1 inhibitor from a high-throughput screen of natural product extracts.

作者: Sung Bum Park , Ji Seon Park , Won Hoon Jung , AReum Park , Sae Rom Jo

DOI: 10.1016/J.PHRS.2015.10.014

关键词:

摘要: Selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) have considerable potential as a treatment for metabolic syndrome including 2 diabetes mellitus and obesity. To identify 11β-HSD1 inhibitors, we conducted high-throughput screening (HTS) active natural product extracts from the Korea Chemical Bank, Tanshinone I, IIA, flavanone derivatives, 2- 3-phenyl-4H-chromen-4-one. Then IIA its derivatives were targeted development lead compound according to HTS results. However, mechanism anti-adipogenic effect through enzyme inhibition by is not clear. (2a) concentration-dependently inhibited activity in human mouse overexpressed cells 3T3-L1 adipocytes. also activities murine liver fats. Furthermore, (2a)-suppressed adipocyte differentiation cortisone-induced adipogenesis was associated with suppression adipogenesis-specific markers mRNA protein expression. In preadipocytes, (2a)-inhibited cortisone induced reactive oxygen species formation concentration-dependent manner. Thus, these results support therapeutic inhibitor patients.

参考文章(45)
TD Brandebourg, CY Hu, None, Regulation of differentiating pig preadipocytes by retinoic acid. Journal of Animal Science. ,vol. 83, pp. 98- 107 ,(2005) , 10.2527/2005.83198X
C F Semenkovich, T Coleman, F T Fiedorek, Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetics of decay after glucose deprivation. Journal of Lipid Research. ,vol. 36, pp. 1507- 1521 ,(1995) , 10.1016/S0022-2275(20)39738-8
Nicholas Houstis, Evan D. Rosen, Eric S. Lander, Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. ,vol. 440, pp. 944- 948 ,(2006) , 10.1038/NATURE04634
Zhenwei Gong, Cheng Huang, Xiaoyan Sheng, Yuebo Zhang, Qunyi Li, Ming-Wei Wang, Linling Peng, Ying Qin Zang, The Role of Tanshinone IIA in the Treatment of Obesity through Peroxisome Proliferator-Activated Receptor γ Antagonism Endocrinology. ,vol. 150, pp. 104- 113 ,(2009) , 10.1210/EN.2008-0322
Yonghan He, Ying Li, Tiantian Zhao, Yanwen Wang, Changhao Sun, Ursolic Acid Inhibits Adipogenesis in 3T3-L1 Adipocytes through LKB1/AMPK Pathway PLoS ONE. ,vol. 8, pp. e70135- ,(2013) , 10.1371/JOURNAL.PONE.0070135
Qinghua Shang, Hao Xu, Li Huang, Tanshinone IIA: A Promising Natural Cardioprotective Agent. Evidence-based Complementary and Alternative Medicine. ,vol. 2012, pp. 716459- 716459 ,(2012) , 10.1155/2012/716459
Stephan Wueest, Reto A. Rapold, Desiree M. Schumann, Julia M. Rytka, Anita Schildknecht, Ori Nov, Alexander V. Chervonsky, Assaf Rudich, Eugen J. Schoenle, Marc Y. Donath, Daniel Konrad, Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice Journal of Clinical Investigation. ,vol. 120, pp. 191- 202 ,(2010) , 10.1172/JCI38388
David J. Hosfield, Yiqin Wu, Robert J. Skene, Mark Hilgers, Andy Jennings, Gyorgy P. Snell, Kathleen Aertgeerts, Conformational Flexibility in Crystal Structures of Human 11β-Hydroxysteroid Dehydrogenase Type I Provide Insights into Glucocorticoid Interconversion and Enzyme Regulation Journal of Biological Chemistry. ,vol. 280, pp. 4639- 4648 ,(2005) , 10.1074/JBC.M411104200